Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00451399
What this trial is testing

Efficacy of Lifestyle Interventions and Metformin for the Treatment of Antipsychotic-Induced Weight Gain

Who this might be right for
Weight Gain
Central South University 128
Large-scale testing (Phase 3)Ended earlyNCT01908192
What this trial is testing

Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®

Who this might be right for
Schizophrenia
SyneuRx International (Taiwan) Corp 60
Large-scale testing (Phase 3)UnknownNCT04528095
What this trial is testing

SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia

Who this might be right for
Treatment-resistant Schizophrenia
Shanghai Mental Health Center 162
Not applicableLooking for participantsNCT01246765
What this trial is testing

National Pregnancy Registry for Psychiatric Medications

Who this might be right for
Pregnant WomenPsychotropic Drugs
Massachusetts General Hospital 5,000
Very early researchStudy completedNCT02708394
What this trial is testing

Molecular Mechanisms of Antipsychotic-induced Insulin Resistance

Who this might be right for
Adverse Effect of Other Antipsychotics and NeurolepticsInsulin Resistance
Wayne State University 31
Post-approval studies (Phase 4)Study completedNCT00297739
What this trial is testing

Risperidone Augmentation for Treatment-Resistant Aggression in ADHD

Who this might be right for
Aggression
Armenteros, Jorge L., M.D., P.A. 25
Large-scale testing (Phase 3)Looking for participantsNCT07008235
What this trial is testing

Effect of Amitriptyline and Trifluoperazine on Patients With Functional Dyspepsia

Who this might be right for
Functional Dyspepsia
Md. Moktadirul Hoque Shuvo 120
Not applicableStudy completedNCT02220504
What this trial is testing

3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals

Who this might be right for
SchizophreniaSchizophrenia RelapseSchizophrenia Spectrum and Other Psychotic Disorders
Fundación Marques de Valdecilla 68
Post-approval studies (Phase 4)Ended earlyNCT02357849
What this trial is testing

Fluoxetine vs Aripiprazole Comparative Trial (FACT)

Who this might be right for
Attenuated Psychosis Syndrome
Northwell Health 9
Large-scale testing (Phase 3)UnknownNCT04093518
What this trial is testing

Estradiol as add-on to Antipsychotics

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorders
Tangent Data 100
Not applicableStudy completedNCT01145313
What this trial is testing

Impact of Atypical Antipsychotic Therapy on Health Outcomes and Costs Among Patients With Major Depressive Disorder

Who this might be right for
Depressive Disorder, Major
Otsuka Pharmaceutical Development & Commercialization, Inc. 501
Post-approval studies (Phase 4)Ended earlyNCT00256997
What this trial is testing

Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their Medication

Who this might be right for
Schizophrenia
Janssen-Ortho Inc., Canada 167
Not applicableStudy completedNCT04851691
What this trial is testing

An Electronic Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions

Who this might be right for
Alzheimer DiseaseDementia AlzheimersDementia of Alzheimer Type
University of California, Los Angeles 158
Not applicableStudy completedNCT03287778
What this trial is testing

Randomized Controlled Trial of Pyridoxine for Tardive Dyskinesia

Who this might be right for
Tardive DyskinesiaAntipsychotic Agents
University of North Carolina, Chapel Hill 17
Not applicableUnknownNCT04335916
What this trial is testing

Survey on Pre-ECT Evaluation and ECT Application

Who this might be right for
DepressionCatatoniaSchizophrenia+3 more
Klinički Bolnički Centar Zagreb 30
Large-scale testing (Phase 3)Study completedNCT02469155
What this trial is testing

A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment

Who this might be right for
Schizophrenia
Intra-Cellular Therapies, Inc. 696
Post-approval studies (Phase 4)Study completedNCT01207414
What this trial is testing

Switching to Iloperidone From Other Antipsychotics in Schizophrenia

Who this might be right for
Schizophrenia
Novartis 501
Not applicableStudy completedNCT03019887
What this trial is testing

Correlation Between Cognitive Function and Relapse of Schizophrenia Regarding Dose Reduction

Who this might be right for
Schizophrenia Relapse
Juntendo University 139
Large-scale testing (Phase 3)Study completedNCT01858948
What this trial is testing

SGA-induced Metabolic Syndrome in Bipolar Youth

Who this might be right for
Bipolar Youth Treated With Second-generation Antipsychotics
University of Cincinnati 19
Large-scale testing (Phase 3)Study completedNCT02194933
What this trial is testing

Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Schizophrenia With Impulsivity

Who this might be right for
Schizophrenia With Impulsivity
Otsuka Pharmaceutical Development & Commercialization, Inc. 38
Next Page